AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast ...
Researchers developing autonomous artificial intelligence research tools say that they’ll soon be able to integrate with lab ...
A formal FDA call for repurposing nominations prioritizes areas where unmet need is high and manufacturer incentives to pursue supplemental approvals are limited. Submissions may be grounded in ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the ...
Many of the most exciting discoveries in science involve highly specialized knowledge and making connections between far-flung facts. Scientists must combine deep analysis with broad reasoning ...
Researchers from the National University of Singapore (NUS) have developed an AI-guided workflow that combines artificial ...
The US Food and Drug Administration (FDA) is asking for input on repurposing older drugs for new therapeutic uses to address unmet medical needs across a wide range of therapeutic areas. FDA said that ...
Liberty Science Center recognized three scientists whose work spans artificial intelligence, drug repurposing and species ...
The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.
The FDA is seeking public input on drug repurposing efforts aimed at expanding treatment options for diseases tied to unmet medical needs. The agency said identifying new uses for FDA-approved drugs ...
Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results